Adaptin Bio APTN
OTC APTN
$6.27 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Adaptin Bio (APTN) Change in Other Operating Liabilities (2023 - 2024)

Updated

Analysis

Adaptin Bio (APTN) Change in Other Operating Liabilities (2023 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Liabilities Change (Qtr)
1 Eli Lilly 1,155.80 Bn 1,124.39 Bn 19.71 Bn -
2 Johnson & Johnson 630.65 Bn 549.18 Bn 17.26 Bn -972.00 Mn
3 AbbVie 502.74 Bn 475.85 Bn 12.70 Bn -
4 Merck 375.34 Bn 329.72 Bn 12.21 Bn -
5 Novartis Ag 301.36 Bn 265.35 Bn 11.24 Bn -
6 Astrazeneca 265.02 Bn 238.70 Bn 12.86 Bn -
7 Amgen 239.16 Bn 194.55 Bn 7.24 Bn -32.00 Mn
8 Gilead Sciences 192.63 Bn 166.82 Bn 6.22 Bn -
9 Pfizer 171.82 Bn 118.47 Bn 10.94 Bn -112.00 Mn
10 Adaptin Bio 56.76 Mn 54.75 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -44,750.00
Sep 30, 2024 4,250.00
Jun 30, 2024 4,250.00
Mar 31, 2024 4,250.00
Dec 31, 2023 4,250.00
Sep 30, 2023 4,250.00
API Access

Adaptin Bio Change in Other Operating Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-liabilities&ticker=APTN&period=max&api_key=YOUR_API_KEY